Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus - Anderssohn, M; Schwedhelm, E; Lüneburg, N (Diab Vasc Dis Res, 2010)
et al.